$11.5 million commitment supports new Alzheimer’s prevention clinical trial (Links to an external site)

Some antiamyloids remove target plaques from the brain, yet don’t seem to halt cognitive decline. Researchers are working to understand why.
School of Medicine scientists honored for innovation